Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Founded by Gisbert Schneider and Matthias Steger in 2016, Endogena is backed by Rejuveron Life Sciences and DEFTA Partners and is headquartered in San Francisco.